Characteristics of a Novel Target Antigen against Myeloma Cells for Immunotherapy

Despite the availability of therapeutic treatments, multiple myeloma is an incurable haematological disorder. In this study, we aimed to clarify the role of CXorf48 as a therapeutic target in multiple myeloma. Based on a previously identified HLA-A*24:02-restiricted epitope from this novel cancer/te...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsushita, Maiko, Saito, Saku, Yokoe, Shinya, Ichikawa, Daiju, Hattori, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712752/
https://www.ncbi.nlm.nih.gov/pubmed/33023190
http://dx.doi.org/10.3390/vaccines8040579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712752/
https://www.ncbi.nlm.nih.gov/pubmed/33023190
http://dx.doi.org/10.3390/vaccines8040579

Ejemplares similares